TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 EUR)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
3
|
2
|
0 |
| Financial expenses |
2
|
2
|
2 |
| Earnings before taxes |
-1
|
-2
|
-3 |
| EBITDA |
1
|
0
|
-1 |
| Total assets |
125
|
137
|
144 |
| Current assets |
5
|
5
|
4 |
| Current liabilities |
77
|
84
|
85 |
| Equity capital |
48
|
54
|
59 |
| - share capital |
8
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
38.4%
|
39.4%
|
41.0% |
| Turnover per employee |
3
|
2
|
0 |
| Profit as a percentage of turnover |
-33.3%
|
-100% | |
| Return on assets (ROA) |
0.8%
|
0%
|
-0.7% |
| Current ratio |
6.5%
|
6.0%
|
4.7% |
| Return on equity (ROE) |
-2.1%
|
-3.7%
|
-5.1% |
| Change turnover |
1
|
2
|
0 |
| Change turnover % | 67% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.